BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 26, 2019
View Archived Issues
New mouse model for intrahepatic cholangiocellular carcinoma reveals protective effect of Pecam-1
Read More
Signaling promotes glucose uptake, brain tumor development
Read More
Novel Dyrk1 inhibitor DYR-219 delays the onset of AD-like pathology in 3xTg-AD mice
Read More
Artesunate modifies T cells to protect against type 1 diabetes
Read More
SNP-162 inhibits growth of sorafenib-resistant liver cancer cell lines
Read More
CStone completes registration filing in Australia for phase I trial of CS-3002 in solid tumors
Read More
NO-releasing polymer NVN-1000 inhibits HPV DNA replication and progeny virus production
Read More
MEIS2 knockdown prevents colorectal cancer cell migration and invasion
Read More
Monoclonal antibody P52E03 protects against H7N9 virus challenge
Read More
Transgenic expression of human STING mutant in hematopoietic cells provides murine SAVI model
Read More
Enrollment ongoing in phase II study of osilodrostat in pediatric patients with Cushing's disease
Read More
FIAsp receives European approval for the management of diabetes in adolescents and children
Read More
Tanabe initiates first-in-human study of TR1801-ADC
Read More
Off-target resistance to TRK inhibitors
Read More
Sunshine Lake Pharma describes new farnesoid X receptor agonists
Read More
Otago Innovation, University of Copenhagen patent CaMK2A ligands
Read More
Anhui New Star Pharmaceutical Development discovers P2Y12 antagonists
Read More
New IDO-1 inhibitors identified at Hinova Pharmaceuticals
Read More
Boehringer Ingelheim presents ghrelin O-acyltransferase inhibitors
Read More
Daewoong's pulmonary fibrosis drug DWN-12088 enters global phase I trial
Read More
Phase III BREEZE-AD7 study of baricitinib in atopic dermatitis meets primary endpoint
Read More
